{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:24:11Z","timestamp":1787235851868,"version":"build-2736575974"},"reference-count":90,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Cytopathology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jasc.2022.12.001","type":"journal-article","created":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T19:50:07Z","timestamp":1672084207000},"page":"89-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The cytologic diagnosis of mesothelioma: are we there yet?"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4729-8644","authenticated-orcid":false,"given":"Claire W.","family":"Michael","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jasc.2022.12.001_bib1","first-page":"81","article-title":"Asbestos and mesothelioma: a review","volume":"13","author":"Kannerstein","year":"1978","journal-title":"Pathol Annu"},{"key":"10.1016\/j.jasc.2022.12.001_bib2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/path.1711430303","article-title":"Diagnosis of pleural malignant mesothelioma in life--a practical approach","volume":"143","author":"Whitaker","year":"1984","journal-title":"J Pathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib3","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1200\/JCO.2013.49.9616","article-title":"Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin and non-Hodgkin lymphoma","volume":"31","author":"Chirieac","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jasc.2022.12.001_bib4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/JTO.0000000000000471","article-title":"High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma","volume":"10","author":"Nasu","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jasc.2022.12.001_bib5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.5858\/arpa.2017-0365-RA","article-title":"Malignant Mesothelioma and Its Non-Asbestos Causes","volume":"142","author":"Attanoos","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2022.12.001_bib6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3109\/00313028009086812","article-title":"Malignant mesothelioma: a review of 35 cases with diagnosis and prognosis","volume":"12","author":"Griffiths","year":"1980","journal-title":"Pathology"},{"key":"10.1016\/j.jasc.2022.12.001_bib7","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1007\/s00268-019-05132-6","article-title":"Largely Unchanged Annual Incidence and Overall Survival of Pleural Mesothelioma in the USA","volume":"43","author":"Keshava","year":"2019","journal-title":"World J Surg"},{"key":"10.1016\/j.jasc.2022.12.001_bib8","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jasc.2022.12.001_bib9","first-page":"162","article-title":"Latency periods in asbestos-related mesothelioma of the pleura","volume":"6","author":"Bianchi","year":"1997","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.jasc.2022.12.001_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/sonc.2002.30237","article-title":"The epidemiology of mesothelioma","volume":"29","author":"Britton","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jasc.2022.12.001_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11864-008-0071-3","article-title":"Systemic treatments for mesothelioma: standard and novel","volume":"9","author":"Kindler","year":"2008","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.jasc.2022.12.001_bib12","series-title":"Mesothelioma in Australia 2020. Cat.no.CAN 143","year":"2021"},{"key":"10.1016\/j.jasc.2022.12.001_bib13","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/cncy.21342","article-title":"The diagnosis of malignant mesothelioma in effusion cytology: a reappraisal and results of a multi-institution survey","volume":"121","author":"Paintal","year":"2013","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib14","series-title":"Sourcebook on Asbestos Disease: Medical, Legal and Engineering Aspects. 4","first-page":"71","article-title":"Early diagnosis of malignant meosthelioma: the contribution of effusion and fine needle aspiration cytology and ancillary techniques","author":"Whitaker","year":"1989"},{"key":"10.1016\/j.jasc.2022.12.001_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/107327480601300402","article-title":"Malignant pleural mesothelioma: a comprehensive review","volume":"13","author":"Ismail-Khan","year":"2006","journal-title":"Cancer Control"},{"key":"10.1016\/j.jasc.2022.12.001_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/sonc.2002.30230","article-title":"Multimodality treatment of diffuse malignant pleural mesothelioma","volume":"29","author":"Zellos","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jasc.2022.12.001_bib17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/path.1700860204","article-title":"The Exfoliative Cytology of Diffuse Malignant Mesothelioma","volume":"86","author":"Naylor","year":"1963","journal-title":"J Pathol Bacteriol"},{"key":"10.1016\/j.jasc.2022.12.001_bib18","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/1097-0142(19820601)49:11<2431::AID-CNCR2820491134>3.0.CO;2-W","article-title":"Malignant mesothelioma of the pleura: review of 123 patients","volume":"49","author":"Brenner","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.jasc.2022.12.001_bib19","first-page":"33","article-title":"Current problems in the pathology of asbestos--related disease","volume":"17 Pt 2","author":"Churg","year":"1982","journal-title":"Pathol Annu"},{"key":"10.1016\/j.jasc.2022.12.001_bib20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/ajcp\/110.3.397","article-title":"Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ: a brief review","volume":"110","author":"Henderson","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2022.12.001_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1365-2303.2000.00247.x","article-title":"The cytology of malignant mesothelioma","volume":"11","author":"Whitaker","year":"2000","journal-title":"Cytopathology"},{"key":"10.1016\/j.jasc.2022.12.001_bib23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5858\/arpa.2015-0240-SA","article-title":"New Markers for Separating Benign from Malignant Mesothelial Proliferations: are we there yet?","volume":"140","author":"Churg","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2022.12.001_bib24","first-page":"19","article-title":"The diagnostic yield of pleural fluid cytology in malignant pleural effusions","volume":"41","author":"Ong","year":"2000","journal-title":"Singapore Med J"},{"key":"10.1016\/j.jasc.2022.12.001_bib25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/1097-0142(196207\/08)15:4<691::AID-CNCR2820150403>3.0.CO;2-L","article-title":"The exfoliative cytology of diffuse pleural mesothelioma","volume":"15","author":"Klempman","year":"1962","journal-title":"Cancer"},{"key":"10.1016\/j.jasc.2022.12.001_bib26","first-page":"807","article-title":"Immunohistochemical differentiation of malignant mesothelioma, mesothelial hyperplasia and metastatic adenocarcinoma in serous effusions, utilizing staining for carcinoembryonic antigen, keratin and vimentin","volume":"31","author":"Duggan","year":"1987","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2022.12.001_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/thx.33.1.26","article-title":"Malignant mesothelioma of the pleura in Barrow-in-Furness","volume":"33","author":"Edge","year":"1978","journal-title":"Thorax"},{"key":"10.1016\/j.jasc.2022.12.001_bib28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1056\/NEJM198007243030407","article-title":"Current concepts: malignant mesothelioma","volume":"303","author":"Antman","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jasc.2022.12.001_bib29","doi-asserted-by":"crossref","first-page":"746","DOI":"10.7326\/0003-4819-96-6-746","article-title":"Diffuse malignant mesothelioma. Prospective evaluation of 69 patients","volume":"96","author":"Chahinian","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jasc.2022.12.001_bib30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0007-0971(83)90068-2","article-title":"Malignant mesothelioma 1982: review of 4710 published cases","volume":"77","author":"Hillerdal","year":"1983","journal-title":"Br J Dis Chest"},{"key":"10.1016\/j.jasc.2022.12.001_bib31","first-page":"268","article-title":"Pathology of human malignant mesothelioma","volume":"8","author":"Suzuki","year":"1980","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jasc.2022.12.001_bib32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1378\/chest.111.1.106","article-title":"The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma","volume":"111","author":"Renshaw","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.jasc.2022.12.001_bib33","series-title":"Mesothelioma, Diagnosis and management","author":"Kittle","year":"1987"},{"key":"10.1016\/j.jasc.2022.12.001_bib34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0046-8177(87)80196-X","volume":"18","author":"Cibas","year":"1987","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib35","first-page":"196","article-title":"The cytologic diagnosis of mesothelioma","volume":"3","author":"Ehya","year":"1986","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib36","first-page":"283","article-title":"Cytologic changes associated with asbestos exposure","volume":"8","author":"Gupta","year":"1981","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jasc.2022.12.001_bib37","first-page":"169","article-title":"Diagnosis and prognosis in malignant pleural mesothelioma: a prospective study","volume":"65","author":"Martensson","year":"1984","journal-title":"Eur J Respir Dis"},{"key":"10.1016\/j.jasc.2022.12.001_bib38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000195200","article-title":"Accuracy of diagnostic procedures in the initial evaluation and follow-up of mesothelioma patients","volume":"51","author":"Strankinga","year":"1987","journal-title":"Respiration"},{"key":"10.1016\/j.jasc.2022.12.001_bib39","first-page":"521","article-title":"Mesothelioma","volume":"29","author":"Edge","year":"1983","journal-title":"Br J Hosp Med"},{"key":"10.1016\/j.jasc.2022.12.001_bib40","series-title":"fascicle: No. 20.\u00a0Tumours and Pseudotumours of the Serous Membranes","author":"McCaughey","year":"1985"},{"key":"10.1016\/j.jasc.2022.12.001_bib41","doi-asserted-by":"crossref","first-page":"893","DOI":"10.5858\/arpa.2018-0020-RA","article-title":"Cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma: ten years of clinical experience in relation to international guidelines","volume":"142","author":"Hjerpe","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2022.12.001_bib42","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/PAT.0b013e32835bc848","article-title":"A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit","volume":"45","author":"Segal","year":"2013","journal-title":"Pathology"},{"key":"10.1016\/j.jasc.2022.12.001_bib43","first-page":"211","article-title":"Cytologic presentation of malignant mesothelioma in pleural effusions","volume":"56","author":"Pedio","year":"1988","journal-title":"Exp Cell Biol"},{"key":"10.1016\/j.jasc.2022.12.001_bib44","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/dc.24475","article-title":"HEG1, BAP1, and MTAP are useful in cytologic diagnosis of malignant mesothelioma with effusion","volume":"49","author":"Hiroshima","year":"2021","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib45","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/PAS.0000000000000529","article-title":"Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens","volume":"40","author":"Hwang","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/cncr.10923","article-title":"The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions","volume":"99","author":"Illei","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jasc.2022.12.001_bib47","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/PAS.0000000000000976","article-title":"Loss of BAP1 Expression in Atypical Mesothelial Proliferations Helps to Predict Malignant Mesothelioma","volume":"42","author":"Pillappa","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib48","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/cyt.12250","article-title":"Guidelines for the Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma: a secondary publication","volume":"26","author":"Hjerpe","year":"2015","journal-title":"Cytopathology"},{"key":"10.1016\/j.jasc.2022.12.001_bib49","series-title":"The International System for Reporting Serous Fluid Cytopathology","author":"Michael","year":"2020"},{"key":"10.1016\/j.jasc.2022.12.001_bib50","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/dc.24663","article-title":"Serous fluid cytopathology: Past, present, and future","volume":"49","author":"Michael","year":"2021","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib51","series-title":"WHO classification of Tumors Editorial Board. Thoracic tumors","article-title":"Tumoursof the pleura and peritoneum","author":"Tsoa","year":"2021"},{"key":"10.1016\/j.jasc.2022.12.001_bib52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pathol.2021.04.011","article-title":"Cytological diagnosis of mesothelioma in situ versus invasive mesothelioma","volume":"54","author":"Churg","year":"2022","journal-title":"Pathology"},{"key":"10.1016\/j.jasc.2022.12.001_bib53","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/pin.13021","article-title":"Development of mesothelioma in situ and its progression to invasive disease observed in a patient with uncontrolled pleural effusions for 15 years","volume":"70","author":"Hidaka","year":"2020","journal-title":"Pathol Int"},{"key":"10.1016\/j.jasc.2022.12.001_bib54","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.pathol.2021.06.124","article-title":"Progression of mesothelioma in situ to invasive disease 4 years and 10 months after initial diagnosis","volume":"54","author":"Klebe","year":"2022","journal-title":"Pathology"},{"key":"10.1016\/j.jasc.2022.12.001_bib55","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.pathol.2020.06.010","article-title":"Malignant mesothelioma in situ: diagnostic and clinical considerations","volume":"52","author":"Pulford","year":"2020","journal-title":"Pathology"},{"key":"10.1016\/j.jasc.2022.12.001_bib56","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/cncy.22548","article-title":"Analysis of early pleural fluid samples in patients with mesothelioma: A case series exploration of morphology, BAP1, and CDKN2A status with implications for the concept of mesothelioma in situ in cytology","volume":"130","author":"Louw","year":"2022","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib57","first-page":"141","article-title":"Malignant mesothelioma: cytologic diagnosis with histologic, immunohistochemical, and ultrastructural correlation","volume":"9","author":"Leong","year":"1992","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib58","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1159\/000328590","article-title":"Methods of cytologic smear preparation and fixation. Effect on the immunoreactivity of commonly used anticytokeratin antibody AE1\/AE3","volume":"44","author":"Shidham","year":"2000","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2022.12.001_bib59","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1159\/000369198","article-title":"The implementation of liquid-based cytology for lung and pleural-based diseases","volume":"58","author":"Michael","year":"2014","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2022.12.001_bib60","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/jclinpath-2012-201303","article-title":"Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers","volume":"66","author":"Henderson","year":"2013","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib61","doi-asserted-by":"crossref","first-page":"933","DOI":"10.5858\/arpa.2020-0119-CP","volume":"144","author":"Roy-Chowdhuri","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2022.12.001_bib62","first-page":"103","article-title":"Discrimination between primary pleural and primary peritoneal mesotheliomas by morphometry and analysis of the vacuolization pattern of the exfoliated mesothelial cells","volume":"26","author":"Boon","year":"1982","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2022.12.001_bib63","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1749-6632.1965.tb41140.x","article-title":"Asbestos and neoplasia: diffuse mesothelial tumors. Criteria for diagnosis of diffuse mesothelial tumors","volume":"132","author":"McCaughey","year":"1965","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jasc.2022.12.001_bib64","first-page":"845","article-title":"Effusion cytology in the diagnosis of malignant epithelioid and biphasic pleural mesothelioma","volume":"114","author":"Sherman","year":"1990","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2022.12.001_bib65","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/thx.37.11.816","article-title":"Pleural biopsy in the diagnosis of malignant mesothelioma","volume":"37","author":"Herbert","year":"1982","journal-title":"Thorax"},{"key":"10.1016\/j.jasc.2022.12.001_bib66","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/(SICI)1097-0339(199710)17:4<272::AID-DC7>3.0.CO;2-E","article-title":"Confocal laser scanning microscopy and three-dimensional reconstruction of cell clusters in serous fluids","volume":"17","author":"Michael","year":"1997","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib67","first-page":"236","article-title":"Cell aggregates in malignant mesothelioma","volume":"21","author":"Whitaker","year":"1977","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2022.12.001_bib68","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/cncy.21345","article-title":"Small orangiophilic squamous-like cells: an underrecognized and useful morphological feature for the diagnosis of malignant mesothelioma in pleural effusion cytology","volume":"122","author":"Chen","year":"2014","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib69","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/1742-6413.99170","article-title":"Parakeratotic-like cells in effusions - A clue to diagnosis of malignant mesothelioma","volume":"9","author":"Gao","year":"2012","journal-title":"Cytojournal"},{"key":"10.1016\/j.jasc.2022.12.001_bib70","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.legalmed.2007.06.001","article-title":"Accuracy and reproducibility of pleural effusion cytology","volume":"10","author":"Fassina","year":"2008","journal-title":"Leg Med"},{"key":"10.1016\/j.jasc.2022.12.001_bib71","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/ajcp\/24.6.663","article-title":"Studies on tumor cells in serous effusion","volume":"24","author":"Takagi","year":"1954","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib72","first-page":"37","article-title":"Malignant mesothelioma. Cytopathology of 75 cases seen in a New Jersey community hospital","volume":"28","author":"Triol","year":"1984","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2022.12.001_bib73","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0046-8177(87)80279-4","article-title":"Distinguishing adenocarcinoma from mesothelioma in effusions","volume":"18","author":"Triol","year":"1987","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib74","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2303.1990.tb00339.x","article-title":"Cytopathology of malignant mesothelioma. Reappraisal of the diagnostic value of collagen cores","volume":"1","author":"Delahaye","year":"1990","journal-title":"Cytopathology"},{"key":"10.1016\/j.jasc.2022.12.001_bib75","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/cncy.21660","article-title":"Young investigator challenge: Validation and optimization of immunohistochemistry protocols for use on cellient cell block specimens","volume":"124","author":"Sauter","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib76","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/dc.24720","article-title":"Immunochemistry in the work-up of mesothelioma and its differential diagnosis and mimickers","volume":"49","author":"Mneimneh","year":"2021","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib77","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/dc.20208","article-title":"The value of epithelial membrane antigen expression in separating benign mesothelial proliferation from malignant mesothelioma: a comparative study","volume":"32","author":"Saad","year":"2005","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib78","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/dc.23521","article-title":"Utility of GATA-3 in the work-Up of breast adenocarcinoma and its differential diagnosis in serous effusions: A Cell-Block Microarray Study","volume":"44","author":"El Hag","year":"2016","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2020.08.005","article-title":"The potential utility of GATA binding protein 3 for diagnosis of malignant pleural mesotheliomas","volume":"105","author":"Prabhakaran","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib80","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.pathol.2020.12.005","article-title":"The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis","volume":"53","author":"Klebe","year":"2021","journal-title":"Pathology"},{"key":"10.1016\/j.jasc.2022.12.001_bib81","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.celrep.2016.03.043","article-title":"MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A\/PRMT5\/RIOK1 Axis","volume":"15","author":"Marjon","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.jasc.2022.12.001_bib82","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/modpathol.2015.87","article-title":"Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology","volume":"28","author":"Andrici","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib83","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/PAS.0000000000001565","article-title":"The Separation of Benign and Malignant Mesothelial Proliferations: New Markers and how to use them","volume":"44","author":"Churg","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib84","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/PAT.0b013e32835d0efb","article-title":"Tumours associated with BAP1 mutations","volume":"45","author":"Murali","year":"2013","journal-title":"Pathology"},{"key":"10.1016\/j.jasc.2022.12.001_bib85","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/PAS.0b013e3182498be5","article-title":"A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression","volume":"36","author":"Wiesner","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib86","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/dc.22896","article-title":"Cytomorphologic features of metastatic urothelial carcinoma in serous effusions","volume":"41","author":"Huang","year":"2013","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib87","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/cyt.12065","article-title":"Cytomorphological features of metastatic squamous cell carcinoma in serous effusions","volume":"25","author":"Huang","year":"2014","journal-title":"Cytopathology"},{"key":"10.1016\/j.jasc.2022.12.001_bib88","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/dc.22902","article-title":"Deciduoid mesothelioma: cytologic presentation and diagnostic pitfalls","volume":"41","author":"Huang","year":"2013","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2022.12.001_bib89","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy-number alteration across human cancers","volume":"463","author":"Beroukhim","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jasc.2022.12.001_bib90","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.8153634","article-title":"A cell cycle regulator potentially involved in genesis of many tumor types","volume":"264","author":"Kamb","year":"1994","journal-title":"Science"}],"container-title":["Journal of the American Society of Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294522002782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294522002782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:47:46Z","timestamp":1761979666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213294522002782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2213294522002782"],"URL":"https:\/\/doi.org\/10.1016\/j.jasc.2022.12.001","relation":{},"ISSN":["2213-2945"],"issn-type":[{"value":"2213-2945","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The cytologic diagnosis of mesothelioma: are we there yet?","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Cytopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jasc.2022.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}